Skip to main content
Robert Molinari, MD, Orthopaedic Surgery, Rochester, NY, Strong Memorial Hospital of the University of Rochester

RobertWMolinariMD

Orthopaedic Surgery • Rochester, NY

Orthopedic Spine Surgery, Orthopedic Trauma

Professor, Orthopaedics and Neurosurgery, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Molinari is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Molinari's full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Orthopaedic Surgery Of The Spine, 1997 - 1998
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiResidency, Orthopaedic Surgery, 1989 - 1993
  • National Capital Consortium
    National Capital ConsortiumInternship, Transitional Year, 1988 - 1989
  • Icahn School of Medicine at Mount Sinai
    Icahn School of Medicine at Mount SinaiClass of 1988

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2003 - Present
  • NY State Medical License
    NY State Medical License 1989 - 2024
  • American Board of Orthopaedic Surgery Orthopaedic Surgery

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Publications & Presentations

PubMed

Press Mentions

  • Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington's Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug Candidate
    Retrotope Announces Publication of Preclinical Research Showing Cognitive Improvements in a Huntington's Disease Model Using Deuterated Polyunsaturated Fatty Acid (D-PUFA) Drug CandidateJuly 9th, 2018
  • US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)
    US FDA Allows Trial to Proceed for Retrotope’s RT001 in the Treatment of Progressive SupraNuclear Palsy (PSP)April 29th, 2020

Hospital Affiliations

Dr. Robert Molinari, Dr. Robert Molinari, MD, Dr. R Molinari, Dr. Robert W Molinari